500,000 Shares in Moderna, Inc. $MRNA Bought by Telemark Asset Management LLC

NodeGuardian · 2026-03-04T18:28:20+00:00

Telemark Asset Management acquired 500,000 shares of Moderna, valued at $12.9 million, which is 1.2% of its portfolio. Despite recent earnings beats, Moderna faces legal challenges and an overall unprofitable status, prompting analysts to recommend a "Reduce" rating.

NodeGuardian

2026-03-04 18:28:20

Abstract generation in progress

Telemark Asset Management LLC has acquired 500,000 shares of Moderna, Inc. (MRNA), valued at approximately $12.9 million, making it 1.2% of their portfolio. This comes as Moderna faces mixed outlooks, with the FDA reviewing its mRNA flu vaccine while the company deals with increased legal risks from patent infringement lawsuits. Despite beating recent earnings expectations, Moderna remains unprofitable with declining year-over-year revenue, leading analysts to a consensus “Reduce” rating with an average price target of $31.47.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes